Cynosure, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 29   

Articles published

CYNO 25.00 +1.33 (5.62%)
price chart
Cynosure, Inc. (CYNO) Misses Q1 EPS by 1c
Cynosure, Inc. (NASDAQ: CYNO) reported Q1 EPS of $0.12, $0.01 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $10.7 million versus the consensus estimate of $38.51 million.
Cynosure (CYNO) Posts Quarterly Results  The Utah People's Post
Related articles »  
PALOMAR MEDICAL TECHNOLOGIES INC : Cynosure and Palomar Announce ...
WESTFORD, Mass. and BURLINGTON, Mass., April 24, 2013 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO) and Palomar Medical Technologies, Inc. (NASDAQ: PMTI) today announced that the 2013 Annual Meeting of Cynosure Stockholders and the ...
Related articles »  
Palomar Medical Technologies Inc (NASDAQ:PMTI) Investor Alert: Lawsuit to ...
San Diego, CA -- (SBWIRE) -- 04/23/2013 -- An investor in shares of Palomar Medical Technologies Inc (NASDAQ:PMTI) filed a lawsuit in effort to halt the proposed takeover of Palomar Medical Technologies Inc by Cynosure, Inc for a value of $13.65 per ...
Weight Loss/Obesity Management Market Worth $361 Billion by 2017
Ethicon Endo-surgery, Inc. (U.S.), Cynosure, Inc. (U.S.), and Allergen, Inc. (U.S.) are eminent players in the Global Weight Loss Surgical Equipment Market.
Related articles »  
PALOMAR MEDICAL TECHNOLOGIES INC : Palomar Medical Reports ...
Mr. Caruso added, "On March 18, we and Cynosure, Inc. jointly announced the execution of a definitive agreement, pursuant to which Cynosure will acquire Palomar and Palomar stockholders will receive $6.825 per Palomar share in cash and $6.825 per ...
Related articles »  
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Claims of ...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of Palomar Medical Technologies Inc. in Connection With Sale of Company to Cynosure Inc. Press Release. Email; Printer Friendly; Share: ...
Related articles »  
Allergan, Mentor and Galderma Lead the Accelerating European Market for ...
Other companies included in the report are Galderma, Zeltiq Aesthetics, Inc., Solta Medical, Cynosure, Syneron/Candela, Alma Laser, Palomar, Merz Pharmaceutical, Lumenis, Asclepion, Inc. Hironic Co, Ltd, DEKA Laser, Laboratoires Teoxane, Cutera, Inc., ...
Related articles »  
Cynosure Q1 13 Earnings Conference Call At 9:00 AM ET - NASDAQ.com
(RTTNews.com) - Cynosure Inc.( CYNO ) will host a conference call at 9:00 AM ETApril 30, 2013, to discuss its Q1 13 earnings results.
Related articles »  
Cynosure Earnings Preview: Can This Streak Continue?
Cynosure Inc. develops and manufactures lasers for medical and aesthetic treatment applications, including leg veins, hair removal, scar revision, port-wine birthmarks, facial spider veins, stretch marks, tattoos, and pigmented lesions.
Related articles »  
Phoenix Skin Acquires The Fastest Laser In The World To Erase Unwanted Tattoos
Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non invasive and minimally invasive procedures to remove hair, treat vascular and pigmented lesions, remove multicolored ...